Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-04-29

Clinical Trial Update: Temozolomide and O6-benzylguanine in Treating Children With Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 trial of temozolomide combined with O6-benzylguanine in children with solid tumors has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • O6-Benzylguanine (O6-Benzylguanine)
  • Temodar (Temozolomide)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Brain and Central Nervous System Tumors, Childhood Germ Cell Tumor | Phase 1 | Status: COMPLETED